BNTX241220C85000
- 15.49
- 0.000.00%
BioNTech Newsroom
BioNTech Price Target Maintained With a $171.00/Share by Canaccord Genuity
BioNTech Is Maintained at Buy by Canaccord Genuity
Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $150 Price Target
BioNTech Analyst Ratings
BioNTech SE: Strong Oncology Pipeline and Financial Position Offset Vaccine Business Uncertainty
BioNTech's Strategic Acquisition of Biotheus Bolsters Oncology Portfolio and Justifies Buy Rating
Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $137
Goldman Sachs Reaffirms Their Buy Rating on BioNTech SE (BNTX)
Futu Morning Post | Suspense Rising Again? Risk of no rate cut by the Fed in December increases, US bonds erase gains for 2024; Foreign giants are making moves! Chinese concept stocks become new targets for additional investment.
BoA's Hartnett: Investment market turning point before inauguration in January, allocating to US bonds, Chinese and European stock markets, gold; 'Most lethal' US Health Secretary nominee, vaccine stocks plummeting for consecutive days; DJT's major shareholder perfect timing to completely reduce shareholding, missing out on 'sudden fortune and wealth'.
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
The "most lethal in history" nomination of the usa Secretary of Health! Vaccine stocks have been plummeting for consecutive days, and Kennedy has been criticized as the number one threat to public health.
On Friday, biontech once fell nearly 9%, moderna fell over 7%, and nasdaq biotechnology index dropped over 4%. Industry insiders said that Kennedy's 'junk science' poses a huge threat to public health.
Form 144 | BioNTech(BNTX.US) Director Proposes to Sell 15.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 15, $BioNTech(BNTX.US)$ Director Jeggle Helmut Wolfgang intends to sell 150K shares of its common stock on Nov 15, with a total market value of approximately $15.53
19th Annual Double Helix Medals Dinner Raises $7 Million
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week
Shares of Vaccine Stocks Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Maintains Target Price $124
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Idexx Laboratories (IDXX)